Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism.
about
Cardiac regulation by phosphoinositide 3-kinases and PTENProtein kinase cascades in the regulation of cardiac hypertrophyTargeted Sprouty1 overexpression in cardiac myocytes does not alter myocardial remodeling or functionTranslational research of adult stem cell therapyMammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats.Myocardial stress remodelling after regional infarction is independent of glycogen synthase kinase-3 inactivation.Influence of the cardiomyocyte circadian clock on cardiac physiology and pathophysiology.Targeting GSK-3 family members in the heart: a very sharp double-edged sword.PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/β-catenin signalling pathway in hepatocellular carcinoma.Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effectsReverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertensionBiomechanics of Cardiac FunctionDual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutationPleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failureDisease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease.Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophyMyocardial AKT: the omnipresent nexus.Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutationAldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stressLeptin signaling in the failing and mechanically unloaded human heart.Morphological and molecular changes of the myocardium after left ventricular mechanical supportLeft ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.Myocardial recovery with mechanical circulatory support.Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress.Tissue inhibitor of metalloproteinase-1 and -3 improves cardiac function in an ischemic cardiomyopathy model rat.Using Phospho-Peptides Immobilized on Magnetic Beads for Absorption Control in Immunohistochemistry.MEK1-induced physiological hypertrophy inhibits chronic post-myocardial infarction remodeling in mice.Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.Mode of perfusion influences infarct size, coronary flow and stress kinases in the isolated mouse heart.Modulation of unloading-induced bone loss in mice with altered ERK signaling.A promoter polymorphism -945C>G in the connective tissue growth factor in heart failure patients with mechanical circulatory support: a new marker for bridge to recovery?
P2860
Q24317248-B0EA77A5-24C6-4AEC-829A-B394457818B2Q24518494-49DEDFBF-422C-4133-B42F-B74CAFF10D09Q24630540-9694B8D2-1A8A-4963-9D47-BB9513DD3953Q26774565-D0F09519-2D79-4A28-A6EA-603244241B21Q33576908-40D2AFE6-A7FE-4B73-8923-5920764A18B2Q34218086-C9DB02CC-8DBD-49C7-A734-8D0394567C7AQ34668879-C98C02A5-A725-478A-BD5A-1C7F912508DEQ34785999-BDA02B5B-78BD-45DE-AF82-E2762EB23E4CQ35132214-9EB1E226-EBB9-4475-AEE8-A581BCB19D21Q36065639-D33EE07E-75BA-4504-B87E-F5DCB32563EFQ36116119-A37D21C5-AC7E-4CE9-872A-B219871558E4Q36343041-6868D159-FDB0-4B86-BE48-9D753AC553D1Q36418867-6FBD1527-5C4A-4212-AE7C-014D369DCF42Q36529070-FAB955F4-77C6-4A05-AAE6-6784D1817647Q36549642-7AF0ACDB-A64C-4A26-9802-1762C731D6A1Q36804940-57829701-24DC-4FA3-A952-2E996F7F5DAFQ36908289-A307B5A6-53E1-48D5-B860-21E3752F95C7Q36932490-7A30C52A-C9BA-4A54-B0CD-BBB1EB20A612Q36979192-82C43FB7-0E85-4246-B863-F128E408947FQ37245162-12FBF2B0-0CF4-4BAB-9CA2-8E5215E3A1EBQ37428292-AEAFB7B7-B3A7-4475-B727-7AE8FB5FBD28Q37638247-EA7921EA-48AB-4A71-84D9-EDFF677C4AB1Q37771886-2590EB3E-A859-4CBA-BE99-14FBEE0CECB3Q38404844-3F0ADEA7-D331-45EA-BF94-8F18CD82B0D4Q38864091-CA3E9085-9177-4177-B07B-4D63D092E67DQ41467221-FC21C361-39ED-4597-A02B-9E90E19A81C6Q41825669-6D58E10C-71FB-4CEE-B838-35D3C716F758Q42803009-3D5BEFB4-2764-435D-8C39-81165B83F0E1Q46199329-A86AFE31-A229-4508-8A68-CC67709CD72AQ46699523-FC260F4F-4D5E-4AC6-ABC0-BA40E9B53846Q47280383-E4943D6B-B6E9-4156-A447-BD09B18C2ADFQ51654903-15A3547B-F53E-44DE-B94F-7F3ADA26F0D7Q52872860-4E8C02AF-A77D-4C89-9CDE-947DC2908D57
P2860
Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Dynamic regulation of MEK/Erks ...... possible molecular mechanism.
@en
Dynamic regulation of MEK/Erks ...... possible molecular mechanism.
@nl
type
label
Dynamic regulation of MEK/Erks ...... possible molecular mechanism.
@en
Dynamic regulation of MEK/Erks ...... possible molecular mechanism.
@nl
prefLabel
Dynamic regulation of MEK/Erks ...... possible molecular mechanism.
@en
Dynamic regulation of MEK/Erks ...... possible molecular mechanism.
@nl
P2093
P1476
Dynamic regulation of MEK/Erks ...... possible molecular mechanism.
@en
P2093
Andrea Sokoll
Atsushi Takeda
Bodo Levkau
Florian Grabellus
Hans H Scheld
Hideo A Baba
Jörg Stypmann
Markus J Wilhelm
Michael Schäfers
Nobuakira Takeda
P304
P356
10.1016/S0008-6363(03)00393-6
P577
2003-08-01T00:00:00Z